| Closed |
SWOG-8900 |
A Phase II Pilot of VAD and VAD/Verapamil for Refractory Multiple Myeloma |
5/1/1989 |
12/1/1991 |
100% |
|
Published
|
| Closed |
SWOG-9107 |
A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer |
1/1/1993 |
8/1/1994 |
70% |
|
Published
|
| Closed |
SWOG-9100 |
A Phase II Pilot Study of High-Dose 24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA in Patients with Pancreatic Adenocarcinoma |
1/15/1993 |
8/1/1994 |
86% |
|
Published
|
| Open |
S2005 |
A PHASE II RANDOMIZED STUDY COMPARING IBRUTINIB AND RITUXIMAB VS. VENETOCLAX AND RITUXIMAB IN PREVIOUSLY UNTREATED WALDENSTROM'S MACROGLOBULINEMIA (WM) /LYMPHOPLASMACYTIC LYMPHOMA (LPL) |
6/24/2021 |
|
10% |
|
|
| Open |
S2104 |
A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors |
10/14/2021 |
|
36% |
|
|
| Closed |
SWOG-9500 |
A Phase II Study of 7 + 3 and High Dose Ara-C Induction Therapy with Sequential High-Dose Ara-C Consolidation Therapy for Adults with De Novo Acute Myeloid Leukemia |
12/15/1995 |
4/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-9143 |
A Phase II Study of Cisplatin Preceded by a 12-hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) for Patients with Untreated Malignant Mesothelioma |
8/15/1992 |
9/15/1994 |
100% |
|
Published
|
| Closed |
SWOG-9148 |
A Phase II Study of Cisplatin Preceded By A 12-Hour Continuous Infusion of Concurrent Hydroxyurea and Cytosine Arabinoside (Ara-C) For Patients with Untreated, Extensive Stage Small Cell and Non… |
9/1/1992 |
6/1/1995 |
58% |
|
|
| Closed |
SWOG-8822 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL-2) in Patients with Malignant Lymphoma |
5/1/1989 |
6/15/1991 |
6% |
|
|
| Closed |
SWOG-8824 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Advanced Renal Cell Carcinoma |
5/1/1989 |
8/15/1991 |
100% |
|
Published
|
| Closed |
SWOG-8830 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Ovarian Cancer |
4/1/1989 |
11/15/1990 |
10% |
|
|
| Closed |
SWOG-8832 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer |
4/1/1989 |
11/15/1990 |
6% |
|
|
| Closed |
S9711 |
A Phase II Study of IL-4 in Patients with Relapsed or Refractory B Lineage Acute Lymphoblastic Leukemia. |
5/15/1997 |
8/15/1998 |
10% |
|
|
| Closed |
SWOG-8735 |
A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia |
4/1/1988 |
5/15/1990 |
57% |
|
|
| Closed |
SWOG-8752 |
A Phase II Study of Recombinant Tumor Necrosis (rTNF) in Patients with Endometrial Cancer |
9/15/1988 |
7/15/1990 |
17% |
|
|
| Closed |
SWOG-8806 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Advanced Bladder Cancer (for patients not eligible for SWOG-8594) |
8/15/1988 |
11/15/1990 |
25% |
|
|
| Closed |
SWOG-8808 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Chronic Myeloid Leukemia |
11/15/1989 |
11/15/1990 |
0% |
|
|
| Closed |
SWOG-8760 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Gastric Carcinoma |
6/15/1988 |
1/1/1990 |
83% |
|
Published
|
| Closed |
SWOG-8743 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients with Metastatic Colorectal Adenocarcinoma |
6/15/1988 |
1/1/1990 |
71% |
|
Published
|
| Closed |
SWOG-8755 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients With Pancreatic Adeno-carcinoma |
6/15/1988 |
1/1/1990 |
|
|
Published
|
